Cutia Therapeutics（wuxi）co.,ltd

This early-stage study tests a new ointment called CU-10101 in 64 people—first in healthy volunteers, then in those with mild-to-moderate atopic dermatitis (eczema). The main goal is to check safety and how the body handles the ointment, not yet to prove it works. Participants ar…